Cited by 56Diabetes Management and ResearchBarrier Structure and Function StudiesPancreatic function and diabetes

Vascular Endothelial Growth Factor: A Novel Endocrine Defensive Response to Hypoglycemia

Dantz, Dorle, Bewersdorf, Jan, Fruehwald-Schultes, Bernd, Kern, Werner, Jelkmann, Wolfgang, Born, Jan, Fehm, Horst L., Peters, Achim·2002·The Journal of Clinical Endocrinology & Metabolism

Abstract

Glucose, the most important fuel for the brain, is supplied by the actions of counterregulatory hormones and the sympathetic nervous system. Yet to obtain access to the brain, glucose must pass the blood-brain barrier. Here we show that vascular endothelial growth factor (VEGF), a potent regulator of blood vessel function, is a candidate hormone for facilitating glucose passage across the blood-brain barrier under critical conditions. In 16 healthy men, VEGF serum concentrations increased under 6 h of insulin-induced hypoglycemic conditions from 86.1 +/- 13.4 to 211.6 +/- 40.8 pg/ml (P = 0.002), whereas in the hyperinsulinemic euglycemic control condition, no change was observed. During hypoglycemia serum VEGF, but no other counterregulatory hormone, was associated with preserved neurocognitive function, as measured with a memory test (r = 0.539; P = 0.031) and the Stroop interference task (r = 0.569; P = 0.021). Findings show that acute hypoglycemia is accompanied by a brisk increase in circulating VEGF concentration and that VEGF could mediate rapid adaptation of the brain to neuroglycopenia.

Integrity signals

Registry

Crossref · 10.1210/jcem.87.2.8215

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The large variability in glycaemic thresholds in type 1 diabetes can probably be explained by different prior hypoglycaemia exposure rates between individuals, the loss of glucagon secretion within years after diagnosis, blunted catecholamine responses and impaired hypoglycaemic awareness.

    “This large variability in glycaemic thresholds in type 1 diabetes can probably be explained by different prior hypoglycaemia exposure rates between individuals [7], the loss of glucagon secretion within years after diagnosis [9, 10], blunted catecholamine responses and impaired hypoglycaemic awareness [11, 12].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dantz, D., Bewersdorf, J., Fruehwald-Schultes, B., Kern, W., Jelkmann, W., Born, J., Fehm, H. L., & Peters, A.
Affiliations
University of Lübeck (DE)
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2002-02
Volume
87
Issue
2
Pages
835-840
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2037402580
Cited by
56
References
42
Citations by year
2023: 1 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 1 · 2017: 1 · 2015: 2 · 2014: 1 · 2013: 2 · 2012: 3
FWCI
2.48
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
Keywords
vascular endothelial growth factor, hypoglycemia, counterregulatory hormones, blood-brain barrier, glucose transport, neuroglycopenia, neurocognitive function, insulin-induced hypoglycemia, hyperinsulinemic-euglycemic clamp, memory, executive function
MeSH terms
Adult, Blood Glucose, Brain, Cognition, Humans, Hyperinsulinism, Hypoglycemia, Insulin, Lymphokines, Male, Memory, Neuropsychological Tests, Osmolar Concentration, Glucose Clamp Technique, Endothelial Growth Factors, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review